Cancer innovation has been a longstanding priority in the current administration. But sometimes overlooked is some of the nation's most sophisticated lung cancer research underway at the Department of Veterans Affairs. This includes applying capacities like modernized electronic health records and artificial intelligence to support groundbreaking innovation. Dr. Michael Kelley, director of the National Precision Oncology Program, and Kenute Myrie, portfolio manager at the VA Office of Research and Development, discuss how the agency is advancing understanding of cancer and improving long-term health outcomes for veterans.
(this only appears for logged-in users)
| Episode: 24
Lung cancer innovation at the agency is looking at technology to improve detection and treatment.
Dr. Michael Kelley, National Program Director for Oncology, VA
Dr. Kenute Myrie, Lead for Precision Oncology, Office of Research and Development, VA